These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 35324881)

  • 1. Lessons Learned from Programmatic Gains in HIV Service Delivery During the COVID-19 Pandemic - 41 PEPFAR-Supported Countries, 2020.
    Fisher KA; Patel SV; Mehta N; Stewart A; Medley A; Dokubo EK; Shang JD; Wright J; Rodas J; Balachandra S; Kitenge F; Mpingulu M; García MC; Bonilla L; Quaye S; Melchior M; Banchongphanith K; Phokhasawad K; Nkanaunena K; Maida A; Couto A; Mizela J; Ibrahim J; Charles OO; Malamba SS; Musoni C; Bolo A; Bunga S; Lolekha R; Kiatchanon W; Bhatia R; Nguyen C; Aberle-Grasse J;
    MMWR Morb Mortal Wkly Rep; 2022 Mar; 71(12):447-452. PubMed ID: 35324881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vital Signs: Progress Toward Eliminating HIV as a Global Public Health Threat Through Scale-Up of Antiretroviral Therapy and Health System Strengthening Supported by the U.S. President's Emergency Plan for AIDS Relief - Worldwide, 2004-2022.
    Chun HM; Dirlikov E; Cox MH; Sherlock MW; Obeng-Aduasare Y; Sato K; Voetsch AC; Ater AD; Romano ER; Tomlinson H; Modi S; Achrekar A; Nkengasong J;
    MMWR Morb Mortal Wkly Rep; 2023 Mar; 72(12):317-324. PubMed ID: 36952290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protecting the gains: analysis of HIV treatment and service delivery programme data and interventions implemented in 19 African countries during COVID-19.
    Bachanas PJ; Chun HM; Mehta N; Aberle-Grasse J; Parris K; Sherlock MW; Lloyd S; Zeh C; Makwepa DK; Kapanda ML; Dokubo EK; Bonono L; Balachandra S; Ehui E; Fonjungo P; Nkoso AM; Mazibuko S; Okello VN; Tefera F; Getachew M; Katiku EM; Mulwa A; Asiimwe FM; Tarumbiswa TF; Auld AF; Nyirenda R; Dos Santos De Louvado AP; Gaspar I; Hong SY; Ashipala L; Obanubi C; Ikpeazu A; Musoni C; Yoboka E; Mthethwa S; Pinini Z; Bunga S; Rumunu J; Magesa DJ; Mutayoba B; Nelson LJ; Katureebe C; Agolory S; Mulenga LB; Nyika P; Mugurungi O; Ellerbrock T; Mitruka K
    J Int AIDS Soc; 2022 Nov; 25(11):e26033. PubMed ID: 36419346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid Scale-up of an Antiretroviral Therapy Program Before and During the COVID-19 Pandemic - Nine States, Nigeria, March 31, 2019-September 30, 2020.
    Dirlikov E; Jahun I; Odafe SF; Obinna O; Onyenuobi C; Ifunanya M; Efuntoye TA; Tingir N; Ene U; Fagbemi A; Meribe C; Bassey O; Ayo A; Fagbamigbe OJ; Amafah J; Bamidele M; Alagi M; Oladipo A; Dalhatu I; Okoye M; Onotu D; Gwamna J; Abrams WA; Conner DA; Nwaohiri A; Carpenter D; Ijeoma UC; Shah S; Tison LI; Shah M; Chun H; Williams-Sherlock M; Boyd AT; Bachanas P; Ikpeazu A; Aliyu GG; Ellerbrock T; Swaminathan M;
    MMWR Morb Mortal Wkly Rep; 2021 Mar; 70(12):421-426. PubMed ID: 33764965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pediatric HIV Case Identification Across 22 PEPFAR-Supported Countries During the COVID-19 Pandemic, October 2019-September 2020.
    Traub AM; Medley A; Gross J; Sloan M; Amzel A; Gleason MM; Fernando NB; Wong V; Grillo MP; Wolf HT; Al-Samarrai T; Frawley A; Segwabe M; Motswere C; Baramperanye E; Nzima V; Mange Mayer M; Balachandra S; N'siesi FX; Longuma HO; Nyembo P; Mazibuko S; Tilahun T; Teferi W; Desinor O; Reginald JL; Simiyu T; Nyabiage L; Mirembe J; Ts'oeu M; Zomba G; Nyangulu M; Wate A; Greenberg Cowan J; Mali D; Pietersen I; Ogundehin D; Onotu D; Ikpeazu A; Niyonsaba E; Bamwesigye J; Mabasa H; Kindra G; Bunga S; Rwegerera F; Machage E; King'ori G; Calnan J; Nazziwa E; Lingenda G; Musokotwane K; Bulaya-Tembo R; Maphosa T; Srivastava M
    MMWR Morb Mortal Wkly Rep; 2022 Jul; 71(28):894-898. PubMed ID: 35834422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Status of Adolescent Testing and Treatment in PEPFAR-Supported Programs, October 2017 to September 2020.
    Hrapcak S; Hast M; Okegbe T; Gross J; Williams J; Patel M; Wolf H; Siberry G; Lee L; Wiersma S; Agaba P; Carpenter D; Rivadeneira E;
    J Acquir Immune Defic Syndr; 2023 May; 93(1):15-24. PubMed ID: 36716723
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Addressing advanced HIV disease and mortality in global HIV programming.
    Boyd AT; Oboho I; Paulin H; Ali H; Godfrey C; Date A; Sean Cavanaugh J
    AIDS Res Ther; 2020 Jul; 17(1):40. PubMed ID: 32650797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pre-exposure prophylaxis (PrEP) uptake and service delivery adaptations during the first wave of the COVID-19 pandemic in 21 PEPFAR-funded countries.
    Kerzner M; De AK; Yee R; Keating R; Djomand G; Stash S; Rana S; Kimmel A; Eakle R; Klucking S; Patel P;
    PLoS One; 2022; 17(4):e0266280. PubMed ID: 35381024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Evaluation of Local Implementing Partner Performance During the First 2 Years of the USAID/PEPFAR Transition.
    White LA; Avery L; Bonanno L; Knight C; Irwin C; Hoeflich K; Kaliel D; Hijazi M; Raulfs-Wang EC
    Glob Health Sci Pract; 2023 Jun; 11(3):. PubMed ID: 37348934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping the impact of the expanded Mexico City Policy for HIV/ family planning service integration in PEPFAR-supported countries: a risk index.
    Sherwood J; Sharp A; Honermann B; Horrigan C; Chatterjee M; Jones A; Cooney C; Millett G
    BMC Public Health; 2018 Sep; 18(1):1116. PubMed ID: 30208876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The United States President's Emergency Plan for AIDS Relief: a story of partnerships and smart investments to turn the tide of the global AIDS pandemic.
    Goosby E; Dybul M; Fauci AS; Fu J; Walsh T; Needle R; Bouey P
    J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 3():S51-6. PubMed ID: 22797740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Supporting the massive scale-up of antiretroviral therapy: the evolution of PEPFAR-supported treatment facilities in South Africa, 2005-2009.
    Larson E; O'Bra H; Brown JW; Mbengashe T; Klausner JD
    BMC Public Health; 2012 Mar; 12():173. PubMed ID: 22404862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PEPFAR's response to the convergence of the HIV and COVID-19 pandemics in Sub-Saharan Africa.
    Golin R; Godfrey C; Firth J; Lee L; Minior T; Phelps BR; Raizes EG; Ake JA; Siberry GK
    J Int AIDS Soc; 2020 Aug; 23(8):e25587. PubMed ID: 32767707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tuberculosis Preventive Treatment Scale-Up Among Antiretroviral Therapy Patients - 16 Countries Supported by the U.S. President's Emergency Plan for AIDS Relief, 2017-2019.
    Melgar M; Nichols C; Cavanaugh JS; Kirking HL; Surie D; Date A; Ahmedov S; Maloney S; Fukunaga R; ;
    MMWR Morb Mortal Wkly Rep; 2020 Mar; 69(12):329-334. PubMed ID: 32214084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV Viral Load Monitoring Among Patients Receiving Antiretroviral Therapy - Eight Sub-Saharan Africa Countries, 2013-2018.
    Lecher SL; Fonjungo P; Ellenberger D; Toure CA; Alemnji G; Bowen N; Basiye F; Beukes A; Carmona S; de Klerk M; Diallo K; Dziuban E; Kiyaga C; Mbah H; Mengistu J; Mots'oane T; Mwangi C; Mwangi JW; Mwasekaga M; N'tale J; Naluguza M; Ssewanyana I; Stevens W; Zungu I; Bhairavabhotla R; Chun H; Gaffga N; Jadczak S; Lloyd S; Nguyen S; Pati R; Sleeman K; Zeh C; Zhang G; Alexander H
    MMWR Morb Mortal Wkly Rep; 2021 May; 70(21):775-778. PubMed ID: 34043612
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increase in Antiretroviral Therapy Enrollment Among Persons with HIV Infection During the Lusaka HIV Treatment Surge - Lusaka Province, Zambia, January 2018-June 2019.
    Boyd MA; Shah M; Barradas DT; Herce M; Mulenga LB; Lumpa M; Ishimbulo S; Saadani A; Mumba M; Essiet-Gibson I; Tally L; Minchella P; Kancheya N; Mwila A; Zyambo K; Chungu C; Chanda S; Mbewe W; Zulu I; Siansalama T; Mweebo K; Nkwemu K; Simpungwe J; Medley A; Sikazwe I; Mwale C; Agolory S; Ellerbrock T
    MMWR Morb Mortal Wkly Rep; 2020 Aug; 69(31):1039-1043. PubMed ID: 32759917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of COVID-19 on HIV Adolescent Programming in 16 Countries With USAID-Supported PEPFAR Programs.
    Okegbe T; Williams J; Plourde KF; Oliver K; Ddamulira B; Caparrelli K;
    J Acquir Immune Defic Syndr; 2023 Aug; 93(4):261-271. PubMed ID: 36989134
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the impact of the US President's Emergency Plan for AIDS Relief on HIV treatment and prevention programmes in Africa.
    Heaton LM; Bouey PD; Fu J; Stover J; Fowler TB; Lyerla R; Mahy M
    Sex Transm Infect; 2015 Dec; 91(8):615-20. PubMed ID: 26056389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis Preventive Treatment Update - U.S. President's Emergency Plan for AIDS Relief, 36 Countries, 2016-2023.
    Ajiboye AS; O'Connor S; Smith JP; Ahmedov S; Coggin WL; Charles M; Ghosh S; Pierre P; Shah N; Teran RA; Moonan PK; Date A
    MMWR Morb Mortal Wkly Rep; 2024 Mar; 73(11):233-238. PubMed ID: 38512767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of COVID-19 on multi-month dispensing (MMD) policies for antiretroviral therapy (ART) and MMD uptake in 21 PEPFAR-supported countries: a multi-country analysis.
    Bailey LE; Siberry GK; Agaba P; Douglas M; Clinkscales JR; Godfrey C
    J Int AIDS Soc; 2021 Oct; 24 Suppl 6(Suppl 6):e25794. PubMed ID: 34713578
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.